MK-6186

DB12999InvestigationalSmall molecule

MK6186 has been used in trials studying the treatment of HIV-1 Infection.

Chemical structure of MK-6186
Formula / weight
C21H12Cl2N6O · 435.27 g/mol (avg)
Code names
MK6186

Resolves to

Compound
UNIIK3978U665MCAS1034474-19-5ChEMBLCHEMBL1939499PubChem24988948
Structure
InChIKeyFZBAOOQVQXATRL-UHFFFAOYSA-NSMILESClC1=CC(OC2=C3C=NN(CC4=NNC5=NC=CC=C45)C3=CC=C2Cl)=CC(=C1)C#N
Targets
P03366gag-pol

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with MK-6186, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In